Endometriosis Australia has appointed Alexis Wolfe as its Chief Executive Officer. Endometriosis Australia is a nationally accredited charity that endeavours to increase recognition to endometriosis, provide endometriosis education programs and funds endometriosis research.
In announcing the appointment, Chair of Endometriosis Australia Professor Jason Abbott, said: “Alexis comes to Endometriosis Australia with a wealth of knowledge in the not-for-profit/charity sector.
“Having already worked with the organisation in an advisory role, she has hit the ground running. We look forward to her leadership and advocacy for those with endometriosis and those who care for and about them.”
Alexis has over 15 years of experience in marketing and philanthropy, most recently at Mission Australia as a member of their Marketing & Fundraising leadership team, and securing over $50 million in donations, during her tenure. Prior to this, Alexis forged her career working in experiential marketing for renowned agency Maverick Marketing for clients including Coca-Cola, Nestle, Westpac, and Toyota.
Ms Wolfe said: “I have long been an admirer of the dedication and progress Endometriosis Australia has made advocating for this disease which affects 830,000 Australian women and those who identify as non-binary. There continues to be an incredible opportunity to further advance awareness, education, treatment options, and research and I look forward to continuing Endometriosis Australia’s leadership across all areas.
Endometriosis is no longer a silent disease. It is slowly but surely becoming a familiar term in the community. However, many affected by the disease still hide their symptoms from family, friends and colleagues leaving them isolated, vulnerable, and in fear of losing their jobs.
I remain committed to Endometriosis Australia’s collaborative approach working with like-minded women’s health organisations, government, patients, philanthropists, clinicians, ambassadors, volunteers, and supporters to increase awareness and deliver quality outcomes for those living with endometriosis.” Ms Wolfe said.